Pliant Therapeutics' Series A Round

Pliant Therapeutics raised a round of funding on February 18, 2016. Investors include Third Rock Ventures.

Pliant Therapeutics is an early-stage biotechnology company harnessing the therapeutic capabilities of integrin biology and TGF-β signaling to develop breakthrough treatments for fibrotic diseases. B…

Articles about Pliant Therapeutics' Series A Round: